drugset
drugset / Trial / NCT04597359

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

NCT04597359 ↗

Phase 2 Active not recruiting 360 enrolled ECOG-ACRIN Cancer Research Group National Cancer Institute (NCI) · collab
RandomizedParallel-groupDouble-blindPrevention

Summary

This phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance. Green tea catechins may stabilize prostate cancer and lower the chance of prostate growing.

Timeline

Start
2021-10-05
Primary completion
2026-12-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Sinecatechins Unknown — Oral

Indications

prostate carcinoma